T1 Species 857 860 rat
T2 Gene 484 530 cell adhesion molecules ICAM-1 and Î±4-integrin
T3 Level 568 603 activated platelets on cancer cells
T4 Disease 1161 1169 toxicity
T5 Condition 966 972 cancer
T6 Condition 918 924 cancer
T7 Level 406 410 cell
T8 Species 897 901 mice
T9 Disease 1044 1049 toxic
T10 Disease 1161 1166 toxic
T12 Level 1441 1445 cell
T13 Level 434 438 cell
T14 Condition 168 174 cancer
T15 Condition 67 73 cancer
T16 Biomarker 229 234 HAMPT
T17 Level 484 488 cell
T18 Level 598 602 cell
T20 Disease 1510 1518 toxicity
T21 Level 735 747 cancer cells
T22 Condition 650 656 cancer
T23 Level 448 452 cell
T24 Biomarker 1064 1069 HAMPT
T25 Level 721 747 HAMPT induced cancer cells
T26 Level 1405 1446 drugs to restrain circulating tumor cells
T27 Disease 1510 1515 toxic
T28 Condition 1345 1351 cancer
T29 Level 650 687 cancer cells to the underlying stroma
T30 Level 422 439 endothelial cells
T31 Level 742 746 cell
T32 Species 203 206 rat
T33 Species 713 716 rat
T34 Condition 320 326 cancer
T36 Biomarker 721 726 HAMPT
T38 Level 657 661 cell
T39 Biomarker 886 888 kg
T40 Condition 591 597 cancer
T41 Level 918 930 cancer cells
T42 Disease 1044 1052 toxicity
T43 Biomarker 1092 1094 kg
T44 Level 399 411 cancer cells
T45 Biomarker 532 537 HAMPT
T46 Disease 1196 1201 toxic
T47 Condition 399 405 cancer
T48 Level 650 662 cancer cells
T49 Level 787 791 cell
T50 Cellular_component 443 463 extracellular matrix
T51 Biomarker 1089 1091 mg
T52 Biomarker 803 811 Four-day
T53 Biomarker 867 872 HAMPT
T54 Level 837 848 30-day oral
T55 Biomarker 874 885 33.5-134 mg
T56 Biomarker 1268 1270 kg
T57 Level 925 929 cell
T58 Condition 735 741 cancer
T59 Biomarker 343 376 pharmaceutically-formulated HAMPT
